Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model
ESL-treated cells revealed G2/M phase cell cycle arrest.
»
09/04/24
Examining the evolving landscape of liver cancer burden in the United States from 1990 to 2019
Marked increase in ASIR of LC.
»
09/04/24
CD25+FOXP3+CD45-minus; regulatory T-cell infiltration as a prognostic biomarker for endometrial carcinoma
High CD45RA+ stromal cell count associated with superficial myometrial invasion.
»
09/04/24
Adrenal tumours in patients with pathogenic APC mutations: a retrospective study
Prevalence of adrenal tumours among patients with APC mutations twice to three times higher.
»
09/03/24
NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer
NAC1 knockdown reduced CSC markers and tumor cell proliferation and migration.
»
09/06/24
Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance
ACBP/DBI neutralization slowed down breast cancer and NSCLC development.
»
09/06/24
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
Cell death profoundly augmented by concomitant administration of Bcl-xL/Bcl2/Bcl-w inhibitor ABT-263.
»
09/06/24
Acceptability of de-intensified screening for women at low risk of breast cancer: a randomised online experimental survey
Higher breast cancer knowledge positively associated with cognitive and emotional acceptability of screening approach.
»
09/06/24
A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer.
Serum levels of hTERT and m-RUNX3 significantly higher in early GC group.
»
06/15/24
ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of Resistance to Targeted Therapy.
Chemotherapy resistance promotes acquisition of immunogenic neoantigens in ARID1A-deficient tumors.
»
09/18/23
< Prev
Next >